CRIS CURIS INC
Nasdaq · SEC CIK 1108205 · EDGAR
- Bought, last 12 months
- $5,487 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 63 since 2021-12-06, latest 2026-07-09 16:12
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| KAITIN KENNETH I | Dir | $5,487 | — |
| Zung Jonathan B. | CDO | — | — |
| Duvall Diantha | CFO | — | — |
| Hamdy Ahmed MD | CMO | — | — |
| Rubin Marc | Dir | — | — |
| Dentzer James E | Pres, CEO, Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 07:51 | 2026-03-31 | CRIS | KAITIN KENNETH I | Dir | P - Purchase | $0.5487 | +10.0K | 11.4K | +711% | +$5,487 | |
| D | 2026-03-23 | 2026-03-20 | CRIS | Rubin Marc | Dir | C - Cnv Deriv | — | +26.7K | 28.1K | +1,851% | — |
| D | 2026-03-23 | 2026-03-20 | CRIS | Duvall Diantha | CFO | C - Cnv Deriv | — | +66.7K | 77.7K | +604% | — |
| D | 2026-03-23 | 2026-03-20 | CRIS | Dentzer James E | Pres, CEO, Dir | C - Cnv Deriv | — | +133.3K | 148.7K | +866% | — |
| D | 2026-03-23 | 2026-03-20 | CRIS | Hamdy Ahmed MD | CMO | C - Cnv Deriv | — | +66.7K | 66.7K | New | — |
| D | 2026-03-23 | 2026-03-20 | CRIS | Zung Jonathan B. | CDO | C - Cnv Deriv | — | +66.7K | 66.7K | New | — |
| DM | 2022-01-31 | 2022-01-27+ | CRIS | Dentzer James E | Pres, CEO, Dir | S - Sale | $3.12 | -5,500 | 64.9K | -8% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations